Abstract
Benzo(a)pyrene (B(a)P) is a potent lung carcinogen mainly derived from tobacco smoking and environmental contamination, however, the molecular mechanisms by which it accelerates the cell cycle progression and induces the abnormal cell proliferation are still far away from understood. Our current analysis of human embryo lung fibroblasts (HELF) showed that B(a)P exposure was able to promote cell cycle G1-S phase transition. This effect was correlated with c-Jun activation because inhibition of c-Jun by its dominant negative mutant (TAM67) reversed B(a)P action on cell cycle with the down-regulation of expression of cyclin D1, pRb and E2F1. Further study found that overexpression of dominant negative mutants of, PI-3K or Akt, dramatically reduced B(a)P-induced the activation of c-Jun and extracellular signaling regulated kinase (ERK), but not c-Jun NH2 terminal kinase (JNK). Inhibition of p53 by either its inhibitor pifithrin-α or p53 siRNA markedly increased B(a)P-induced the activation of c-Jun, Akt and ERK in this context. Take together, our results indicate that c-Jun activation by p53-dependent PI-3K/Akt/ERK pathway is responsible for B(a)P-induced cell cycle alternations in human embryo lung fibroblasts. Crown
Original language | English |
---|---|
Pages (from-to) | 167-175 |
Number of pages | 9 |
Journal | Toxicology Letters |
Volume | 178 |
Issue number | 3 |
DOIs | |
State | Published - May 30 2008 |
Bibliographical note
Funding Information:Grant information : This work was supported by grants of National Natural Science Foundation of China (30671747, 30371206), 973 National Key Basic Research and Development Program (2002 CB 512905), and supported in part by Philip Morris USA Inc., Philip Morris International and NIH/NIEHS (ES012451).
Funding
Grant information : This work was supported by grants of National Natural Science Foundation of China (30671747, 30371206), 973 National Key Basic Research and Development Program (2002 CB 512905), and supported in part by Philip Morris USA Inc., Philip Morris International and NIH/NIEHS (ES012451).
Funders | Funder number |
---|---|
973 National Key Basic Research and Development Program | 2002 CB 512905 |
NIH-NIEHS-SRC | ES012451 |
National Institute of Environmental Health Sciences (NIEHS) | R01ES012451 |
Philip Morris International | |
National Natural Science Foundation of China (NSFC) | 30371206, 30671747 |
Keywords
- Akt
- B(a)P
- Cell cycle
- Signaling pathway
- c-Jun
- p53
ASJC Scopus subject areas
- Toxicology